HealthCare Global Enterprises Limited
HealthCare Global Enterprises Limited Fundamental Analysis
HealthCare Global Enterprises Limited (HCG.BO) shows weak financial fundamentals with a PE ratio of 431.54, profit margin of 0.77%, and ROE of 2.03%. The company generates $24.7B in annual revenue with strong year-over-year growth of 16.25%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 23.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HCG.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakHCG.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateHCG.BO shows balanced valuation metrics.
Growth Score
ModerateHCG.BO shows steady but slowing expansion.
Financial Health Score
WeakHCG.BO carries high financial risk with limited liquidity.
Profitability Score
WeakHCG.BO struggles to sustain strong margins.
Key Financial Metrics
Is HCG.BO Expensive or Cheap?
P/E Ratio
HCG.BO trades at 431.54 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, HCG.BO's PEG of -9.33 indicates potential undervaluation.
Price to Book
The market values HealthCare Global Enterprises Limited at 8.88 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 16.01 times EBITDA. This signals the market has high growth expectations.
How Well Does HCG.BO Make Money?
Net Profit Margin
For every $100 in sales, HealthCare Global Enterprises Limited keeps $0.77 as profit after all expenses.
Operating Margin
Core operations generate 33.17 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.03 in profit for every $100 of shareholder equity.
ROA
HealthCare Global Enterprises Limited generates $0.53 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
HealthCare Global Enterprises Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
HealthCare Global Enterprises Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
HCG.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
431.54
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-9.33
vs 25 benchmark
P/B Ratio
Price to book value ratio
8.88
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.92
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.73
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.005
vs 25 benchmark
ROCE
Return on capital employed
0.32
vs 25 benchmark
How HCG.BO Stacks Against Its Sector Peers
| Metric | HCG.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 431.54 | 29.45 | Worse (Expensive) |
| ROE | 2.03% | 779.00% | Weak |
| Net Margin | 0.77% | -24936.00% (disorted) | Weak |
| Debt/Equity | 1.92 | 0.26 | Weak (High Leverage) |
| Current Ratio | 0.73 | 4.65 | Weak Liquidity |
| ROA | 0.53% | -19344.00% (disorted) | Weak |
HCG.BO outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews HealthCare Global Enterprises Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
29.04%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
126.47%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
54.99%
Industry Style: Defensive, Growth, Innovation
High Growth